ANDREW MASSAR: Open Payments
NPI 1205506748 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 15 payments from 9 companies in 2025. Trend: 2023 $900 · 2024 $610 · 2025 $479
Food & beverage: $294Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $126 |
| SEAGEN INC. | 1 | $100 |
| Endo USA, Inc. | 3 | $59 |
| Sumitomo Pharma America, Inc. | 2 | $54 |
| Astellas Pharma US Inc | 2 | $39 |
| Teleflex LLC | 1 | $36 |
| UROGEN PHARMA, INC. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $25 |
| Laborie Medical Technologies Corp. | 1 | $13 |
Products named: ERLEADA, ORGOVYX, XIAFLEX, Xtandi, UROLIFT, JELMYTO, XYOSTED, RYBREVANT.
Industry payments across MI — which companies pay providers there.
